9OFQ | pdb_00009ofq

HCoV-229E S2P bound by one DH1533 Fab


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.88 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

A potently neutralizing human antibody induces movement of the HCoV-229E receptor binding domain

Liccione, M.F.Scobey, T.Froggatt, H.M.Pajon, C.Yount, B.L.Yin, Q.Spence, T.N.Walter, E.B.Saunders, K.O.Edwards, R.J.Baric, R.S.Haynes, B.F.Cain, D.W.Sheahan, T.P.Wrapp, D.

To be published.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Surface glycoproteinA [auth C],
B [auth A],
E [auth B]
1,134Human coronavirus 229EMutation(s): 0 
UniProt
Find proteins for A0A1B3TN99 (Human coronavirus 229E)
Explore A0A1B3TN99 
Go to UniProtKB:  A0A1B3TN99
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A1B3TN99
Glycosylation
Glycosylation Sites: 21
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
DH1533 FAB heavy chainC [auth H]239Homo sapiensMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 3
MoleculeChains Sequence LengthOrganismDetailsImage
DH1533 FAB light chainD [auth L]214Homo sapiensMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Oligosaccharides

Help

Entity ID: 4
MoleculeChains Length2D Diagram Glycosylation3D Interactions
alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
BB [auth 1],
DB [auth 3],
F [auth D],
KA [auth k],
OA [auth o],
BB [auth 1],
DB [auth 3],
F [auth D],
KA [auth k],
OA [auth o],
T,
V
5N-Glycosylation
Entity ID: 5
MoleculeChains Length2D Diagram Glycosylation3D Interactions
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
BA [auth b],
CA [auth c],
G [auth E],
H [auth F],
MA [auth m],
BA [auth b],
CA [auth c],
G [auth E],
H [auth F],
MA [auth m],
RA [auth r],
VA [auth v],
W
3N-Glycosylation
Entity ID: 6
MoleculeChains Length2D Diagram Glycosylation3D Interactions
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
AA [auth a],
DA [auth d],
EA [auth e],
EB [auth 4],
FA [auth f],
AA [auth a],
DA [auth d],
EA [auth e],
EB [auth 4],
FA [auth f],
GA [auth g],
HA [auth h],
I [auth G],
IA [auth i],
J [auth I],
K [auth J],
L [auth K],
M,
N,
NA [auth n],
O,
P,
PA [auth p],
Q,
QA [auth q],
R,
SA [auth s],
UA [auth u],
WA [auth w],
XA [auth x],
YA [auth y],
Z,
ZA [auth z]
2N-Glycosylation
Entity ID: 7
MoleculeChains Length2D Diagram Glycosylation3D Interactions
alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranoseAB [auth 0],
CB [auth 2],
LA [auth l],
S,
U
4N-Glycosylation
Entity ID: 8
MoleculeChains Length2D Diagram Glycosylation3D Interactions
alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
X
6N-Glycosylation
Entity ID: 9
MoleculeChains Length2D Diagram Glycosylation3D Interactions
alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranoseJA [auth j],
TA [auth t],
Y
4N-Glycosylation
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG
Query on NAG

Download Ideal Coordinates CCD File 
FB [auth C]
GB [auth C]
HB [auth C]
IB [auth C]
JB [auth C]
FB [auth C],
GB [auth C],
HB [auth C],
IB [auth C],
JB [auth C],
KB [auth A],
LB [auth A],
MB [auth A],
NB [auth A],
OB [auth A],
PB [auth A],
QB [auth A],
RB [auth A],
SB [auth B],
TB [auth B],
UB [auth B],
VB [auth B],
WB [auth B]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.88 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
RECONSTRUCTIONcryoSPARCv4.6.2
MODEL REFINEMENTISOLDE

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data

  • Released Date: 2025-12-03 
  • Deposition Author(s): Wrapp, D.

Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United States3P01AI158571-01A1S1

Revision History  (Full details and data files)

  • Version 1.0: 2025-12-03
    Type: Initial release